A detailed history of Wealth Spring Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Spring Partners, LLC holds 2,456 shares of ABBV stock, worth $492,354. This represents 0.27% of its overall portfolio holdings.

Number of Shares
2,456
Previous 2,456 -0.0%
Holding current value
$492,354
Previous $331 Million 10.67%
% of portfolio
0.27%
Previous 0.24%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 03, 2023

BUY
$132.51 - $164.9 $10,335 - $12,862
78 Added 3.28%
2,456 $331 Million
Q1 2023

May 03, 2023

SELL
$144.61 - $166.54 $578,440 - $666,160
-4,000 Reduced 62.72%
2,378 $379 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $193,634 - $232,218
1,400 Added 28.12%
6,378 $1.03 Billion
Q3 2022

Feb 08, 2023

BUY
$134.21 - $153.93 $668,097 - $766,263
4,978 New
4,978 $668 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $354B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Spring Partners, LLC Portfolio

Follow Wealth Spring Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Spring Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Spring Partners, LLC with notifications on news.